Age impacts pharmacogenomics and treatment outcomes for the most common form of leukemia (IMAGE)

St. Jude Children's Research Hospital

Age impacts pharmacogenomics and treatment outcomes for the most common form of leukemia

Caption

Jun J. Yang, PhD, St. Jude Departments of Pharmacy and Pharmaceutical Sciences and Oncology and first co-authors Zhenhua Li, PhD, and Satoshi Yoshimura, MD, PhD, demonstrated that treatment and age impact outcomes for B-cell acute lymphoblastic leukemia.

Credit

Courtesy of St. Jude Children's Research Hospital

Usage Restrictions

none

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.